Literature DB >> 2908507

Factors affecting the natural history of human immunodeficiency virus infection.

A J Pinching1.   

Abstract

Human immunodeficiency virus (HIV) establishes latent infection in CD4 lymphocytes and macrophages. It can destroy CD4 cells by direct virus cytotoxicity, indirectly through the host response against HIV-infected cells, or by both means. Cells of the macrophage lineage are generally not destroyed but can serve as a reservoir of virus. HIV also causes functional impairment in remaining infected and uninfected cells. After exposure to infection by sexual, blood or maternofetal contact, about half the contacts become infected with HIV. Factors influencing the inoculum derived from the infected person include type of contact, phase of infection and local factors enhancing HIV replication or excretion. In the exposed person, genetic factors and systemic or local events such as infection or inflammatory injury may influence relative susceptibility. After infection with HIV, a number of outcomes may be seen, including symptomless carriage, with or without lymphadenopathy, or symptomatic disease, including the AIDS-related complex, acquired immune deficiency syndrome and HIV encephalopathy. Infection, multiple pregnancy and infancy are associated with increased or more rapid progression to symptomatic disease; malnutrition and immunosuppressive drugs may exert a similar effect. Genetic factors appear to affect disease susceptibility. Mechanisms influencing progression can be divided into those affecting the rate of HIV replication, those that determine the host response to HIV, and those mediated by other immunosuppressive influences. The host's balance with HIV thus resembles that of a tightrope walker, any force tending to tip him towards a catastrophic and irretrievable decline.

Entities:  

Mesh:

Year:  1988        PMID: 2908507

Source DB:  PubMed          Journal:  Immunodefic Rev        ISSN: 0893-5300


  7 in total

Review 1.  AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.

Authors:  A J Pinching
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

Review 2.  Is human T-cell lymphotropic virus type I really silent?

Authors:  B Asquith; E Hanon; G P Taylor; C R Bangham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-08-29       Impact factor: 6.237

Review 3.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

4.  HIV-I infection in perinatally exposed siblings and twins. The Italian Register for HIV Infection in Children.

Authors:  M de Martino; P A Tovo; L Galli; D Caselli; C Gabiano; P L Mazzoni; A Giacomelli; M Duse; C Fundarò
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

5.  The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase.

Authors:  K E Nye; G A Riley; A J Pinching
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.

Authors:  Nyoman Sri Budayanti; Tuti Parwati Merati; Budiman Bela; Gusti Ngurah Mahardika
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

7.  OUR COMMON ENEMY: COMBATTING THE WORLD'S DEADLIEST VIRUSES TO ENSURE EQUITY HEALTH CARE IN DEVELOPING NATIONS.

Authors:  John J Carvalho
Journal:  Zygon       Date:  2009-02-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.